Form D · Pharmaceuticals
EPIOMED THERAPEUTICS, INC.
Irvine, CA · CIK 0001575661
Offering snapshot reported May 1, 2013 · SEC filing
- Reported sold
- $2.25M Offering amount: $3M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $2.25M Reported outside-investor minimum
- First sale
- May 31, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 1, 2013 | Initial | $2,249,999 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-195820
Source: Form D, filed May 1, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David R. Helton | Director, Executive |
| Gordon Mc Cauley | Director |
| James Miller | Director |
| Theodore Ming Teh Yang | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
25 Mauchly, Suite 316
Irvine, CA, 92618
Irvine, CA, 92618